Meeting
2018 Gastrointestinal Cancers Symposium
The impact of tumor genomic profile on the effectiveness of adjuvant chemotherapy in resectable intrahepatic cholangiocarcinoma.
Authors
Rebecca Marcus
University of Texas MD Anderson Cancer Center, Houston, TX
Rebecca Marcus , Heather A. Lillemoe , Reham Abdel-Wahab , Rachna T. Shroff , Milind M. Javle , Thomas A. Aloia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 474)
DOI
10.1200/JCO.2018.36.4_suppl.474
Abstract #
474
Poster Bd #
M21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2018 Gastrointestinal Cancers Symposium
Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next-generation sequencing.
First Author: Jianzhen Lin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Immunohistochemical and genetic profiles do not predict behavior of mixed hepatocellular intrahepatic cholangiocarcinoma.
First Author: Santiago Sucre
Poster
2021 ASCO Annual Meeting
Multimodal profiling of biliary tract cancers to detect potentially actionable biomarkers and differences in immune signatures between subtypes.
First Author: Kabir Mody